메뉴 건너뛰기




Volumn 6, Issue 4, 2009, Pages 297-304

Bayesian design using adult data to augment pediatric trials

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BAYES THEOREM; CHILD; CLINICAL EFFECTIVENESS; CLINICAL RESEARCH; DRUG EFFICACY; FEASIBILITY STUDY; HUMAN; METHODOLOGY; NORMAL DISTRIBUTION; PRIORITY JOURNAL; SAMPLE SIZE; SENSITIVITY ANALYSIS; VARIANCE; ADOLESCENT; AGE; CLINICAL TRIAL (TOPIC); FEMALE; INFORMATION PROCESSING; MALE; RESEARCH; STATISTICAL ANALYSIS; STATISTICAL MODEL; YOUNG ADULT;

EID: 70449723061     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774509339238     Document Type: Article
Times cited : (57)

References (23)
  • 1
    • 33947429261 scopus 로고    scopus 로고
    • Considerations in the rational design and conduct of phase I/II pediatric clinical trials: Avoiding the problems and pitfalls
    • [Review]
    • Abdel-Rahman SM, Reed MD, Wells TG, Kearns GL Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and pitfalls. [Review]. Clin Pharmacol Ther 2007; 81: 483-94.
    • (2007) Clin Pharmacol Ther , vol.81 , pp. 483-494
    • Abdel-Rahman, S.M.1    Reed, M.D.2    Wells, T.G.3    Kearns, G.L.4
  • 2
    • 0036138407 scopus 로고    scopus 로고
    • Pediatric clinical trials: Shall we take a lead?
    • [comment]
    • Schreiner MS, Greeley WJ Pediatric clinical trials: Shall we take a lead? [comment]. Anesth Analg 2002; 94: 1-3.
    • (2002) Anesth Analg , vol.94 , pp. 1-3
    • Schreiner, M.S.1    Greeley, W.J.2
  • 4
    • 70449728484 scopus 로고    scopus 로고
    • Bridging studies
    • In Chow SC. (ed.). Marcel Dekker, New York
    • Liu JP Bridging studies. In Chow SC. (ed.). Encyclopedia of Biopharmaceutical Statistcs, Marcel Dekker, New York, 2003, pp. 134-38.
    • (2003) Encyclopedia of Biopharmaceutical Statistcs , pp. 134-138
    • Liu, J.P.1
  • 5
    • 0036428684 scopus 로고    scopus 로고
    • Bayesian approach to evaluation of bridging studies
    • Liu JP, Hsiao CF, Hsueh H. Bayesian approach to evaluation of bridging studies. J Biopharm Stat 2002; 12: 401 - 08.
    • (2002) J Biopharm Stat , vol.12 , pp. 401-408
    • Liu, J.P.1    Hsiao, C.F.2    Hsueh, H.3
  • 6
    • 0026014245 scopus 로고
    • Bayesian subset analysis
    • Dixon DO, Simon R. Bayesian subset analysis. Biometrics 1991; 47: 871-81.
    • (1991) Biometrics , vol.47 , pp. 871-881
    • Dixon, D.O.1    Simon, R.2
  • 8
    • 24944463173 scopus 로고    scopus 로고
    • A Bayesian approaches to randomized controlled trials in children utilizing information from adults: The case of Guillain-Barre syndrome
    • Goodman SN, Sladky JT A Bayesian approaches to randomized controlled trials in children utilizing information from adults: The case of Guillain-Barre syndrome. Clin Trials 2005; 2: 305-10.
    • (2005) Clin Trials , vol.2 , pp. 305-310
    • Goodman, S.N.1    Sladky, J.T.2
  • 9
    • 0028798488 scopus 로고
    • Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care
    • Lau J., Schmid CH, Chalmers TC Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol 1995; 48: 45-57.
    • (1995) J Clin Epidemiol , vol.48 , pp. 45-57
    • Lau, J.1    Schmid, C.H.2    Chalmers, T.C.3
  • 10
    • 0029898186 scopus 로고    scopus 로고
    • Meta-analysis in the design and monitoring of clinical trials
    • DerSimonian R. Meta-analysis in the design and monitoring of clinical trials. Stat Med 1996; 15: 1237-48.
    • (1996) Stat Med , vol.15 , pp. 1237-1248
    • DerSimonian, R.1
  • 11
    • 0002083004 scopus 로고    scopus 로고
    • Power prior distributions for regression models
    • Ibrahim JG, Chen MH Power prior distributions for regression models. Stat Sci 2000; 15: 46-60.
    • (2000) Stat Sci , vol.15 , pp. 46-60
    • Ibrahim, J.G.1    Chen, M.H.2
  • 12
    • 67649376266 scopus 로고    scopus 로고
    • The reltaionship between the power prior and hierarchical models
    • Chen MH, Ibrahim JG The reltaionship between the power prior and hierarchical models. Bayesian Anal 2006; 1: 551-74.
    • (2006) Bayesian Anal , vol.1 , pp. 551-574
    • Chen, M.H.1    Ibrahim, J.G.2
  • 13
    • 84928772798 scopus 로고    scopus 로고
    • Available at: (accessed 26 May)
    • The BUGS project. Available at: http://www.mrcbsu.cam.ac.uk/bugs/winbugs/ contents.shtml (accessed 26 May 2009)
    • (2009) The BUGS Project
  • 14
    • 0030664978 scopus 로고    scopus 로고
    • Large sample Bayesian inference on the parameters of the proportional hazard models
    • Faraggi D., Simon RM Large sample Bayesian inference on the parameters of the proportional hazard models. Stat Med 1997; 16: 2573-85.
    • (1997) Stat Med , vol.16 , pp. 2573-2585
    • Faraggi, D.1    Simon, R.M.2
  • 15
    • 0034021941 scopus 로고    scopus 로고
    • Approximate Bayesian evaluation of multiple treatment effects
    • Thall PF, Simon RM, Shen Y. Approximate Bayesian evaluation of multiple treatment effects. Biometrics 2000; 56: 213-9.
    • (2000) Biometrics , vol.56 , pp. 213-219
    • Thall, P.F.1    Simon, R.M.2    Shen, Y.3
  • 17
  • 18
    • 0036345669 scopus 로고    scopus 로고
    • Statistical evaluation of ventilator free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome
    • Schoenfeld DA, Bernard GR Statistical evaluation of ventilator free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002; 30: 1772-7.
    • (2002) Crit Care Med , vol.30 , pp. 1772-1777
    • Schoenfeld, D.A.1    Bernard, G.R.2
  • 19
    • 0035826096 scopus 로고    scopus 로고
    • Efficacy and safety of recombinant human activated protein C for severe sepsis?
    • Bernard GR, Vincent J-L., Laterre P-F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis? N Engl J Med 2001; 344: 699-709.
    • (2001) N Engl J Med , vol.344 , pp. 699-709
    • Bernard, G.R.1    Vincent, J.-L.2    Laterre, P.-F.3
  • 21
    • 0033051086 scopus 로고    scopus 로고
    • Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans
    • Schwartz JI, Chan C. -C, Mukhopadhyay S., et al. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. Clin Pharmacol Ther 1999; 65: 653-60.
    • (1999) Clin Pharmacol Ther , vol.65 , pp. 653-660
    • Schwartz, J.I.1    Chan, C.-C.2    Mukhopadhyay, S.3
  • 22
    • 24344474345 scopus 로고    scopus 로고
    • Aspirin compared with acetaminophen in the treatment of feverand other symptoms of upper respiratory tract infection in adults: A multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study
    • Bachert C., Chuchalin AG, Eisebitt R., et al. Aspirin compared with acetaminophen in the treatment of feverand other symptoms of upper respiratory tract infection in adults: A multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study. Clin Ther 2005; 27: 993-1003.
    • (2005) Clin Ther , vol.27 , pp. 993-1003
    • Bachert, C.1    Chuchalin, A.G.2    Eisebitt, R.3
  • 23
    • 0030734342 scopus 로고    scopus 로고
    • Equivalent antipyretic activity of ibuprofen and paracetamol in febrile children
    • Vauzelle-Kervroedan F., d'Athis P., Pariente-Khayat A., et al. Equivalent antipyretic activity of ibuprofen and paracetamol in febrile children. J Pediatr 1997; 131: 683-7.
    • (1997) J Pediatr , vol.131 , pp. 683-687
    • Vauzelle-Kervroedan, F.1    d'Athis, P.2    Pariente-Khayat, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.